{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T12:40:32Z","timestamp":1702730432204},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"4","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s40121-015-0089-3","type":"journal-article","created":{"date-parts":[[2015,9,21]],"date-time":"2015-09-21T06:40:31Z","timestamp":1442817631000},"page":"425-432","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["In Vitro Activity of Oral Cephalosporins (Cefprozil and Cefixime) Against Ciprofloxacin-Resistant Enterobacteriaceae from Community-Acquired Urinary-Tract Infections"],"prefix":"10.1007","volume":"4","author":[{"given":"Aikaterini","family":"Pistiki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Tsaganos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Galani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelos J.","family":"Giamarellos-Bourboulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,21]]},"reference":[{"issue":"1","key":"89_CR1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijantimicag.2007.02.017","volume":"30","author":"Z Alexiou","year":"2007","unstructured":"Alexiou Z, Mouktaroudi M, Koratzanis G, Papadopoulos A, Kavatha D, Kanellakopoulou K, et al. The significance of compliance for the success of antimicrobial prophylaxis in recurrent lower urinary tract infections: the Greek experience. Int J Antimicrob Agents. 2007;30(1):40\u20133.","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"89_CR2","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/j.1464-410X.2011.10528.x","volume":"109","author":"IM Cullen","year":"2012","unstructured":"Cullen IM, Manecksha RP, McCullagh E, Ahamd S, O\u2019Kelly F, Flynn RJ, et al. The changing pattern of antimicrobial resistance within 42033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999\u20132009. BJU Int. 2012;109(8):1198\u2013206.","journal-title":"BJU Int"},{"issue":"1","key":"89_CR3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijantimicag.2009.08.018","volume":"35","author":"I Katsarolis","year":"2010","unstructured":"Katsarolis I, Poulakou G, Athanasia S, Kourea-Kremastinou J, Lambri N, Karaiskos E, et al. Acute uncomplicated cystitis: from surveillance data to a rationale for empirical treatment. Int J Antimicrob Agents. 2010;35(1):62\u20137.","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"89_CR4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2165\/00003495-199345020-00008","volume":"45","author":"LR Wiseman","year":"1993","unstructured":"Wiseman LR, Benfield P. Cefprozil. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential. Drugs. 1993;45(2):295\u2013317.","journal-title":"Drugs"},{"issue":"Suppl 3","key":"89_CR5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1469-0691.2000.tb02051.x","volume":"6","author":"JM Hamilton-Miller","year":"2000","unstructured":"Hamilton-Miller JM. Overview of cefixime use in community-acquired infections. Clin Microbiol Infect. 2000;6(Suppl 3):79\u201381.","journal-title":"Clin Microbiol Infect"},{"key":"89_CR6","unstructured":"European Committee on Antimicrobial Susceptibility Testing: Clinical Breakpoints 2014 http:\/\/www.eucast.org\/clinical_breakpoints . Accessed Dec 2014."},{"issue":"4","key":"89_CR7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0163-4453(03)00096-3","volume":"47","author":"E St\u00fcrenburg","year":"2003","unstructured":"St\u00fcrenburg E, Mack D. Extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J Infect. 2003;47(4):273\u201395.","journal-title":"J Infect"},{"issue":"2","key":"89_CR8","first-page":"401","volume":"50","author":"EM Thompson","year":"1994","unstructured":"Thompson EM, Shaughnessy AF. Oral cephalosporins: newer agents and their place in therapy. Am Fam Physician. 1994;50(2):401\u20135.","journal-title":"Am Fam Physician"},{"issue":"5","key":"89_CR9","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","volume":"52","author":"K Gupta","year":"2011","unstructured":"Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):e103\u201320.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"89_CR10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ijantimicag.2014.05.020","volume":"44","author":"M Kresken","year":"2014","unstructured":"Kresken M, Pfeifer Y, Hafner D, Wresch R, K\u00f6rber-Irrgang B. Occurrence of multidrug resistance to oral antibiotics among Escherichia coli urine isolates from outpatient departments in Germany: extended-spectrum \u03b2-lactamases and the role of fosfomycin. Int J Antimicrob Agents. 2014;44(4):295\u2013300.","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"89_CR11","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.clinthera.2013.03.022","volume":"35","author":"SK Bouchillon","year":"2013","unstructured":"Bouchillon SK, Badal RE, Hoban DJ, Hawser SP. Antimicrobial susceptibility of inpatient urinary tract isolates from Gram-negative bacilli in the Unites States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009\u20132011. Clin Ther. 2013;35(6):872\u20137.","journal-title":"Clin Ther"},{"issue":"4","key":"89_CR12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s15010-011-0132-6","volume":"39","author":"S Meier","year":"2011","unstructured":"Meier S, Webere R, Zbinden R, Ruef C, Hasse B. Extended-spectrum \u03b2-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy. Infection. 2011;39(4):333\u201340.","journal-title":"Infection"},{"issue":"9","key":"89_CR13","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1742-1241.2012.02991.x","volume":"66","author":"LS Briongos-Figuero","year":"2012","unstructured":"Briongos-Figuero LS, G\u00f3mez-Traveso T, Bachiller-Luque P, Dom\u00ednguez-Gil Gonz\u00e1lez M, G\u00f3mez-Nieto A, et al. Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing enterobacteria. Int J Clin Pract. 2012;66(9):891\u20136.","journal-title":"Int J Clin Pract"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-015-0089-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T19:52:17Z","timestamp":1498247537000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40121-015-0089-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,21]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["89"],"URL":"https:\/\/doi.org\/10.1007\/s40121-015-0089-3","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,21]]}}}